Invasive aspergillosis in the setting of cardiac transplantation.

Among patients undergoing heart transplantation, Aspergillus is the opportunistic pathogen with the highest attributable mortality. The median time of onset from transplantation for invasive pulmonary aspergillosis (IPA) was 46 days, but the median time to first positive culture result was 104 days among patients with Aspergillus colonization but no invasive disease. Most patients with IPA presented with fever and cough within the first 90 days of transplantation and with single or multiple pulmonary nodules. None of the heart transplant recipients with either IPA or invasive extrapulmonary aspergillosis (IEPA) had associated neutropenia. Human leukocyte antigen A1 locus was found significantly more frequently among patients colonized with Aspergillus than among patients with IPA (P<.006) or IEPA (P<.001). Even in the absence of neutropenia, IPA should be suspected for heart transplant recipients who have fever and respiratory symptoms within the first 3 months of transplantation, have a positive result of culture of respiratory secretions, and have abnormal radiological findings (particularly nodules).

[1]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[2]  L. Ekelund,et al.  Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. , 2002, Acta radiologica.

[3]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  B Efron,et al.  Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  E. Spitznagel,et al.  Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. , 2000, The Journal of allergy and clinical immunology.

[7]  P. Grossi,et al.  Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.

[8]  William R. Kirkpatrick,et al.  Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.

[9]  W. Siegert,et al.  Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. , 1999, Blood.

[10]  P E Oyer,et al.  Thirty years of cardiac transplantation at Stanford university. , 1999, The Journal of thoracic and cardiovascular surgery.

[11]  A. Leung,et al.  Pulmonary infections after bone marrow transplantation: clinical and radiographic findings. , 1999, Radiology.

[12]  S. Hunt.  Current status of cardiac transplantation. , 1998, JAMA.

[13]  P. Muñoz,et al.  Pneumonia After Heart Transplantation: A Multiinstitutional Study , 1998 .

[14]  N. Müller,et al.  Invasive aspergillosis in the immunocompromised host: utility of computed tomography and bronchoalveolar lavage. , 1998, Clinical radiology.

[15]  A. Mehta,et al.  Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. Muñoz,et al.  Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Kirschmann,et al.  The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. , 1997, Journal of immunology.

[18]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[19]  J. Latgé,et al.  Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.

[20]  S. Hunt,et al.  Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. , 1997, Transplantation proceedings.

[21]  R. Slavin,et al.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. , 1996, The Journal of clinical investigation.

[22]  D. Denning.  Diagnosis and management of invasive aspergillosis. , 1996, Current clinical topics in infectious diseases.

[23]  A. Husain,et al.  Aspergillus and lung transplantation. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  R. Rubin,et al.  Clinical aspects of fungal infection in organ transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Austin,et al.  Lung nodules and masses after cardiac transplantation. , 1993, Radiology.

[26]  R. De Maria,et al.  Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  E. Fishman,et al.  CT of invasive pulmonary aspergillosis. , 1988, AJR. American journal of roentgenology.

[28]  P E Oyer,et al.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. , 1987, Annals of internal medicine.

[29]  E. Fishman,et al.  Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. , 1985, Radiology.

[30]  B. Strom,et al.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.

[31]  C. Stratton,et al.  Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. , 1983, The Journal of infectious diseases.

[32]  H. Malech,et al.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. , 1981, The American journal of medicine.

[33]  R. Britt,et al.  Intracranial infection in cardiac transplant recipients , 1981, Annals of neurology.

[34]  W. Baumgartner,et al.  Cardiac homotransplantation. , 1979, Current problems in surgery.

[35]  W. Baumgartner,et al.  Current expectations in cardiac transplantation. , 1978, The Journal of thoracic and cardiovascular surgery.

[36]  L. Hovelius,et al.  Report of Five Cases , 1977 .

[37]  E. Stinson,et al.  Aspergillus infection complicating cardiac transplantation. Report of five cases. , 1971, Archives of internal medicine.